VITROLIFE AB       SK 0,2
VITROLIFE AB SK 0,2
Share · SE0011205202 · A2JLT3 (XSTO)
Overview
No Price
Closing Price XSTO 28.01.2026: 120,60 SEK
28.01.2026 16:29
Current Prices from VITROLIFE AB SK 0,2
ExchangeTickerCurrencyLast TradePriceDaily Change
XSTO: NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
VITR.ST
SEK
28.01.2026 16:29
120,60 SEK
-0,50 SEK
-0,41 %
XHAM: Hamburg
Hamburg
VABNAS02.HAMB
EUR
28.01.2026 07:11
11,50 EUR
0,18 EUR
+1,59 %
XFRA: Frankfurt
Frankfurt
VTFN.F
EUR
28.01.2026 07:02
11,28 EUR
-0,04 EUR
-0,35 %
XHAN: Hannover
Hannover
VABNAS02.HANB
EUR
28.01.2026 07:01
11,48 EUR
0,16 EUR
+1,41 %
XDQU: Quotrix
Quotrix
VABNAS02.DUSD
EUR
28.01.2026 06:27
11,53 EUR
0,21 EUR
+1,86 %
XDUS: Düsseldorf
Düsseldorf
VABNAS02.DUSB
EUR
27.01.2026 18:31
11,37 EUR
-0,13 EUR
-1,13 %
Share Float & Liquidity
Free Float 55,41 %
Shares Float 75,04 M
Shares Outstanding 135,42 M
Invested Funds

The following funds have invested in VITROLIFE AB SK 0,2:

Fund
iShares OMX Stockholm Capped UCITS ETF
Vol. in million
28.758,21
Percentage (%)
0,42 %
Company Profile for VITROLIFE AB SK 0,2 Share
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.
AI Analysis of VITROLIFE AB SK 0,2
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of VITROLIFE AB SK 0,2
No AI threads available for this company yet.

Company Data

Name VITROLIFE AB SK 0,2
Company Vitrolife AB (publ)
Website https://www.vitrolife.com
Primary Exchange XSTO NASDAQ STOCKHOLM AB
WKN A2JLT3
ISIN SE0011205202
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Bronwyn Brophy O'Connor
Market Capitalization 16 Mrd.
Country Sweden
Currency SEK
Employees 1,2 T
Address Gustaf Werners gata 2, 421 32 Gothenburg
IPO Date 2001-06-28

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB VITR.ST
Düsseldorf VABNAS02.DUSB
Frankfurt VTFN.F
Hamburg VABNAS02.HAMB
Hannover VABNAS02.HANB
Quotrix VABNAS02.DUSD
More Shares
Investors who hold VITROLIFE AB SK 0,2 also have the following shares in their portfolio:
ALPHABET INC - CLASS C
ALPHABET INC - CLASS C Share
BFCM 20/30 MTN
BFCM 20/30 MTN Bond
DOMINION ENERGY 16/26
DOMINION ENERGY 16/26 Bond
FERRARI N.V.
FERRARI N.V. Share
LENZING AG
LENZING AG Share
LGUE-CL.EN.E. EOA
LGUE-CL.EN.E. EOA ETF
META PLATFORMS INC
META PLATFORMS INC Share
PFIZER INC
PFIZER INC Share
PIERER MOBILITY AG
PIERER MOBILITY AG Share
SYMRISE AG
SYMRISE AG Share
VERBIO VEREINIGTE BIOENERGIE AG
VERBIO VEREINIGTE BIOENERGIE AG Share
VERBUND AG
VERBUND AG Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026